Viewing Study NCT00441688



Ignite Creation Date: 2024-05-05 @ 5:23 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00441688
Status: COMPLETED
Last Update Posted: 2017-08-22
First Post: 2007-02-28

Brief Title: Prospective Epidemiological Study Of The Prevalence Of HLAB5701 In HIV-1 Infected Patients
Sponsor: ViiV Healthcare
Organization: ViiV Healthcare

Study Overview

Official Title: Prospective Epidemiological Study of the Prevalence of HLAB5701 in HIV-1 Infected Patients
Status: COMPLETED
Status Verified Date: 2017-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study is a cross sectional observational study to evaluate the prevalence of HLA-B5701 in the major French ethnotypes

Any HIV-1 infected subject will be eligible for this study including antiretroviral therapy ART naÃ-ve and experienced subjects irrespective of abacavir use as well as subjects previously tested for HLA-B5701 Subjects will be approached during a standard clinic visit and all subjects will be consented prior to any study specific procedure Subjects will be asked to provide a tissue sample cheek cells and blood sample which will be used to assess HLA-B5701 status by central and local methodologies
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None